课题基金 / 基金详情

Frontiers in Fundamental and Translational Immunology

Frontiers in Fundamental and Translational Immunology
基础和转化免疫学前沿
批准号:
10318101
负责人:
Linda Mac Pherson Bradley
金额:
$14.93万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-01 至 2023-06-02
关键词:

项目摘要

项目成果

Linda Mac Pherson Bradley的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
PROJECT SUMMARY This proposal seeks support to establish an innovative multi-thematic postdoctoral training program in fundamental and translational immunology to address the role of innate and adaptive immune cells in various disease contexts. Emphasis is placed on understanding the cellular and molecular basis of immune cell activation in the appropriate context of an immune response to infectious organisms and toxins, or the dysregulation that occurs in the context of chronic inflammation and autoimmunity. These fundamental insights provide the basis for novel therapeutic approaches in infectious disease, autoimmunity and cancer that will be tested in pre-clinical models. Sanford Burnham Prebys Medical Discovery Institute (SBP) recently implemented its 10-year strategic vision, which focuses on four disease priorities (cancer, autoimmunity, metabolic and neurological disorders) and four cross-cutting scientific themes including epigenetics, metabolism, proteostasis and immunomodulation. The proposed Program is an important element of this vision as we strive to provide the best training environment for postdoctoral scientists interested in immunology research. Scientific research at the Institute is supported by an infrastructure that includes multiple core facilities, thereby providing access to advanced technologies and expert, dedicated personnel. SBP emphasizes a collaborative approach to biomedical research, where teams of scientists with expertise in the biological sciences work together with chemists, structural biologists, engineers, and computational biologists to achieve synergistic accomplishments. This collaborative approach to science is intimately integrated into the culture of the Institute, as demonstrated by the fact that ~30% of all SBP publications are the result of inter- and intra- programmatic collaborations. Notably, 35% of over 500 publications from the preceptors' laboratories are led by postdoctoral trainees who serve as first authors. Postdoctoral trainees in this T32 will join one of 13 research groups focused on aspects of immunology. The trainees will be guided by mentoring committees focused on promoting scientific progress and career development. Seminar programs, workshops, retreats and journal clubs will enrich research training. The trainees will be selected based on scientific and academic accomplishments, suitability for research projects in the thematic areas and commitment to a scientific career that builds upon the postdoc experience. Trainees will be supported for an average of 2 years, but will remain with the program upon achieving independent support. The Program will support three trainees within the network of postdoctoral researchers at SBP. It is expected that matriculants who have completed this Program will have received a well-rounded training experience in cutting-edge patient-focused immunology research and will be well prepared to embark on a variety of independent research and research-related careers in fundamental and translational immunology.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jbc.2022.102738
发表时间: 2023-01
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Ng, Bobby G., Sosicka, Paulina, Xia, Zhijie, Freeze, Hudson H.]
通讯作者: Freeze, Hudson H.
Homozygous truncating variant in MAN2A2 causes a novel congenital disorder of glycosylation with neurological involvement.
MAN2A2 中的纯合截短变异会导致一种新型先天性糖基化疾病,并累及神经系统。
DOI: 10.1136/jmg-2022-108821
发表时间: 2023
期刊: Journal of medical genetics
影响因子: 4
作者: [Mahajan,Sonal, Ng,BobbyGeorge, AlAbdi,Lama, Earnest,PaulDanielJames, Sosicka,Paulina, Patel,Nisha, Helaby,Rana, Abdulwahab,Firdous, He,Miao, Alkuraya,FowzanS, Freeze,HudsonH]
通讯作者: Freeze,HudsonH
Targeting Checkpoint Inhibition in Anti-Tumor Responses
Targeting Checkpoint Inhibition in Anti-Tumor Responses
Regulation of CD4+ T cell responses during chronic viral infection
Regulation of CD4+ T Cell Responses During Chronic Viral Infection
国内基金
海外基金
我国低碳转型的经济学传导机制及政策优化仿真研究:基于行业和地区视角
  • 批准号:
    71173048
  • 项目类别:
    面上项目
  • 资助金额:
    43.0万元
  • 批准年份:
    2011
  • 负责人:
    陈诗一
  • 依托单位: